Cynthia K. Garrett is an attorney in private practice who has been representing Pondimin & Redux Users Since 1998. She is still accepting new Fen Phen Clients. Go to the Free Case Review page to see if your case meets our criteria.
Cynthia K. Garrett is still accepting new Pondimin and Redux clients who qualify to file new or worsened injury claims with the AHP Diet Drug Settlement Trust. Deadlines apply to when an injury must occur in order to qualify for compensation, and when you must file your claim for that injury. See below to learn what deadlines apply to you.
Fen-Phen is the common name of a weight loss protocol heavily marketed in the 1990's that combined phentermine with either fenfluramine (Pondimin) or dexfenfluramine (Redux). Pondimin and Redux were shown to cause damage to the mitral and aortic heart valves; and a serious lung condition called primary pulmonary hypertension. Pondimin and Redux were withdrawn from the U.S. market in 1997.
The AHP Settlement Trust was established to administer the injury claims of registered claimants who used either Pondimin or Redux.
Claims can still be filed for those who are included in either of the two groups below, and meet the Baseline Requirements listed below.
1) Supplemental Claims for worsened injuries may be filed by those who
2) Original Claims may be filed by those who:
Claims must be filed within four years of the new or worsened injury qualifying event.
Those Pondimin and Redux users who met the definition of a Category 1 or 2 Claimant as defined in the Seventh Amendment to the AHP Settlement Agreement - were automatically included as participants in the Seventh Amendment Supplemental Fund unless the claimant filed an opt-out form by November 9, 2004.
The definition of Category 1 includes those who had an unresolved Green Form on file on November 9, 2004, which supported a Level I or II injury.
The definition of Category 2 includes those who:
Participants in the 7th Amendment Supplemental Fund may no longer file claims.